Celcuity (NASDAQ:CELC) issued its earnings results on Thursday. The company reported ($0.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.02, Fidelity Earnings reports.
NASDAQ CELC traded up $0.26 on Friday, reaching $14.30. The company had a trading volume of 4,400 shares, compared to its average volume of 7,599. Celcuity has a 52-week low of $13.49 and a 52-week high of $29.96. The company’s fifty day moving average is $16.28 and its 200 day moving average is $19.76. The company has a quick ratio of 25.26, a current ratio of 25.25 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $157.07 million, a P/E ratio of -19.32 and a beta of 0.65.
A number of brokerages have recently weighed in on CELC. Zacks Investment Research raised Celcuity from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a research report on Friday, October 11th. ValuEngine raised Celcuity from a “hold” rating to a “buy” rating in a research report on Wednesday, October 2nd.
Celcuity Inc, a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the clinical outcomes of cancer patients treated with targeted therapies in the United States. The company's CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it.
See Also: What is a conference call?
Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.